Picture of SAMSUNG BIOLOGICS logo

207940 — SAMSUNG BIOLOGICS News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions

- The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday:

** Britain's Segro <SGRO.L> rejected a higher £13.5 billion ($18.2 billion) takeover bid from Prologis <PLD.N>, escalating a standoff as the U.S. warehousing giant urged its rival's shareholders to push the board to agree a deal.

nL4N43M0CD

** South Korea's Samsung Biologics <207940.KS> will launch a 1.46 billion Swiss francs ($1.81 billion) all-cash bid for Swiss contract drugmaker PolyPeptide <PPGN.S>, the companies said in separate statements.

nL6N43L0AP


(Compiled by Rajarshi Roy and Neil J Kanatt in Bengaluru)

((Neil.JKanatt@thomsonreuters.com))

Recent news on SAMSUNG BIOLOGICS

See all news